This e-mail address is being protected from spambots. You need JavaScript enabled to view it

NEW! Alzheimer’s Disease: Global Markets, Competitors, Pipelines and Opportunities

This report is a comprehensive analysis of the Alzheimer’s disease category. Purchasers will gain thorough knowledge on state-of-the-art science, recommendations on clinical trial design, site selection and trial enrollment and will learn what leading world regulatory bodies want to see as a condition for drug approval. Readers will also obtain information on current and potential competitors as well as requirements for commercial success in the top 8 global markets. The pipeline analysis, which contains profiles of over 200 developmental compounds ranging from pre-clinical to Phase IV initiatives, provides the most in-depth examination of AD research available anywhere. Opportunities for in-licensing and out-licensing are specifically identified. Finally, the report includes interviews with several of the world’s most prominent AD thought-leading physicians in which they share their insights on patients, regulators, payers, therapeutic options, clinical trial design and the pipeline.